**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 103-23-1 |Bis(2-ethylhexyl) adipate | 99 | 203-090-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Limited evidence of a carcinogenic effect.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea.
Inhalation:
May cause respiratory tract irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Clean up spills immediately,
observing precautions in the Protective Equipment section.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Avoid contact
with eyes, skin, and clothing. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 103-23-1:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149
approved full-facepiece airline respirator in the
positive pressure mode with emergency escape
provisions.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear, colorless
Odor: aromatic odor
pH: Not available.
Vapor Pressure: 8.5107 mm Hg
Viscosity: Not available.
Boiling Point: 417 deg C
Freezing/Melting Point: -67 deg C
Autoignition Temperature: 350 deg C ( 662.00 deg F)
Flash Point: 196 deg C ( 384.80 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: immiscible
Specific Gravity/Density: .920 g/ml
Molecular Formula: C22H42O4
Molecular Weight: 370.57
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 103-23-1: AU9700000
LD50/LC50:
CAS# 103-23-1: Oral, mouse: LD50 = 15000 mg/kg; Oral, rat: LD50 =
7392 mg/kg; Skin, rabbit: LD50 = 16 mL/kg; Skin, rabbit: LD50 = 8410
mg/kg/24H.
Carcinogenicity:
Bis(2-ethylhexyl) adipate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 103-23-1: 1
Canada
CAS# 103-23-1 is listed on Canada's DSL List.
CAS# 103-23-1 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 103-23-1 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 8/06/1998 Revision #3 Date: 8/17/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Piperonal, 99%
| 120-57-0 |
|
5-Chlorouracil, 99%
| 1820-81-1 |
|
Benzáa??anthracene-7,12-dione, 97% (uv-vis)
| 2498-66-0 |
|
(3,4-Dimethoxyphenyl)acetic acid, 99%
| 93-40-3 |
|
1-Naphthaleneacetamide, 98%
| 86-86-2 |
|
Chlorosulfonyl isocyanate, 98+%
| 1189-71-5 |
|
4-Chloro-4'-Fluorobutyrophenone, 97+% (GC)
| 3874-54-2 |
|
Vitamin d2 (calciferol),99% (hplc)
| 50-14-6 |
|
Diethyl Phosphonoacetaldehyde Diethyl Acetal, Tech. 90%
| 7598-61-0 |
|
3,5-Dimethoxyacetophenone, 97%
| 39151-19-4 |
|
Palladium on Activated Carbon (5% Pd)
| |
|
Cyclododecene, Tech., Predominantly Trans
| 1501-82-2 |
|
4-Hydroxy-6-methyl-2-pyrone
| 675-10-5 |
|
Benzoyl bromide, 97%
| 618-32-6 |
|
Prostaglandin e1, 98+%
| 745-65-3 |
|
4,4'-Dimethylbenzil, 99+%
| 3457-48-5 |
|
Chrysoidin
| 532-82-1 |
|
d-Limonene
| 5989-27-5 |
|
Mitomycin C (Contains 2mg Mitomycin C and 48mg Sodium Chloride)
| 50-07-7 |
|
Butyl methacrylate/isobutyl methacrylate copolymer, high molecular
| 9011-53-4 |
|
Bis-(2-Methylallyl)Cycloocta-1,5-Diene Ruthenium(II) Complex
| 0-00-1 |
|
d-Lysergic acid hydrate, 95% *** controled product kb 11.6.87 ***
| 82-58-6 |
|
2-Bromo-1-Indanol, 99%
| 5400-80-6 |
|
Ruthenium(IV) oxide hydrate
| 32740-79-7 |
|
2-Chlorocyclohexanol, Tech., 90%
| 1561-86-0 |
|
5-Amino-2,2,4-Trimethyl-1-Cyclopentane-Methylamine, 99%, Mixture of
| 67907-32-8 |
|
2,3,4-Trimethoxybenzoic acid, 98+%
| 573-11-5 |
|
1,3-Dibromo-5,5-dimethylhydantoin, 98%
| 77-48-5 |
|
Dicumarol, 99%
| 66-76-2 |
|
Tetraphenylphosphonium Chloride 99%
| 2001-45-8 |
|
Benzo[k]fluoranthene, 99+% (tlc)
| 207-08-9 |
|
Dihexylamine, 99+% (GC)
| 143-16-8 |
|
Propargyl Alcohol, 99%
| 107-19-7 |
|
Borane-tert-butylamine complex, powder
| 7337-45-3 |
|
Tri-n-butyltin methoxide, 97%
| 1067-52-3 |
|
5-Methoxyindole-3-Carboxaldehyde, 99+%
| 10601-19-1 |
|
2,4-Dichlorophenoxyacetic acid
| 94-75-7 |
|
4-Phenylpyridine, 99%
| 939-23-1 |
|
2-Naphthalenesulfonic acid hydrate, 99%
| 120-18-3 |
|
Benzanthrone, 99%
| 82-05-3 |
|
Tripentylamine, 99%
| 621-77-2 |
|
BOC-D-Arginine Hydrochloride, Hydrate, 99%
| 114622-81-0 |
|
Phenylphosphonothioic dichloride, 97%
| 3497-00-5 |
|
3,3,5,5-Tetramethylpyrroline-N-Oxide, 98%
| 10135-38-3 |
|
1-(2-Aminoethyl)-2-Methyl-5-Nitroimidazole Dihydrochloride
| 49575-10-2 |
|
Bis(2-ethylhexyl) adipate
| 103-23-1 |
|
M-Tolyl Acetate
| 122-46-3 |
|
1,4-Dioxa-8-azaspiro(4.5)decane, 98%
| 177-11-7 |
|
DL-Homocysteinethiolactone Hydrochloride, 99%
| 6038-19-3 |
|
Ethyl Benzoate, 99+%
| 93-89-0 |
|
|